Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma
Weiming Han,Wei Deng,Qifeng Wang,Wenjie Ni,Chen Li,Zongmei Zhou,Jun Liang,Dongfu Chen,Qinfu Feng,Nan Bi,Tao Zhang,Xin Wang,Lei Deng,Wenqing Wang,Wenyang Liu,Jianyang Wang,Qi Xue,Yousheng Mao,Xiangyang Liu,Dekang Fang,Jian Li,Dali Wang,Jun Zhao,Zefen Xiao
DOI: https://doi.org/10.3389/fonc.2022.998238
IF: 4.7
2022-11-10
Frontiers in Oncology
Abstract:Background: It is still uncertain whether the newly released eighth American Joint Committee on Cancer (AJCC) post-neoadjuvant pathologic (yp) tumor-node-metastasis (TNM) stage for esophageal carcinoma can perform well regarding patient stratification. The current study aimed to assess the prognostication ability of the eighth AJCC ypTNM staging system and attempted to explore how to facilitate the staging system for more effective evaluation of prognosis. Materials and methods: A total of 486 patients treated with neoadjuvant radiotherapy/chemoradiotherapy (nRT/CRT) were enrolled. ypN stage was reclassified by recursive partitioning. Prognostic performance, monotonicity, homogeneity, and discriminatory of yp and modified yp (myp) staging systems were assessed by time-dependent receiver operating characteristic (ROC), linear trend log-rank test, likelihood ratio χ2 test, Harrell's c statistic, and Akaike information criterion (AIC). Results: The ypT stage, ypN stage, and pathologic response were significant prognostic factors of overall survival. Survival was not discriminated well using the eighth AJCC ypN stage and ypTNM stage. Recursive partitioning reclassified mypN0-N2 as metastasis in 0, 1–2, and ≥3 regional lymph nodes. Applying the ypT stage, mypN stage, and pathologic response to construct the myp staging system, the myp stage performed better in time-dependent ROC, linear trend log-rank test, likelihood ratio χ2 test, Harrell's c statistic, and AIC. Conclusions: The eighth AJCC ypTNM staging system performed well in differentiating prognosis to some extent. By reclassifying the ypN stage and enrolling pathologic response as a staging element, the myp staging system holds significant potential for prognostic discrimination.
oncology